Induced by infection, the conditions of sepsis, severe sepsis, and septic shock are a major public health concern and a leading cause of mortality and critical illness worldwide. This is especially true in the intensive care unit (ICU), as sepsis is the leading cause of death in this clinical setting.
Induced by infection, the conditions of sepsis, severe sepsis, and septic shock are a major public health concern and a leading cause of mortality and critical illness worldwide. This is especially true in the intensive care unit (ICU), as sepsis is the leading cause of death in this clinical setting. 1 In addition to the morbidity and mortality concerns for the patient, sepsis is a significant financial burden and can account for over 5% of total hospital costs. 1 A number of factors have led to this trend, including increases in the aging population and the incidence of immune suppression, which includes cancer and antibiotic resistance. 1 Efforts to define and clinically characterize sepsis as a syndrome are confounded by the lack of a validated criterion establishing a diagnostic test. In the clinical pathology laboratory, a number of tests have been used to support the clinical and therapeutic management of these patients, to include the use of procalcitonin, cytokine analysis, and flow cytometry. More specifically in the clinical microbiology laboratory, strategies such as rapid identification of organisms circulating in the bloodstream by proteomics and nucleic acid amplification multiplex testing, rapid antibiotic susceptibility testing, and the use of antibiotic stewardship programs are being used. Determining the etiology of bloodstream infections is most often accomplished by the use of automated incubation and continuous monitoring of blood culture bottles. The fill volume for these bottles is critical for rapid and sensitive detection. 2 Underfilling of bottles has recently been addressed in a College of American Pathologists (CAP) initiative stating that clinical microbiology laboratories should have a system in place for monitoring blood culture volumes (MIC.22640). 3 This is due to the well-known correlation between fill volume and diagnostic yield, and therefore each manufacturer provides recommended fill volumes on the labels of its bottles as approved by the US Food and Drug Administration. 4, 5 Through efforts to measure blood culture volumes, we have discovered that our institution struggles with achieving the manufacturer-recommended blood culture fill volume of 8 to 10 mL per bottle. A number of factors have led to blood culture bottles being underfilled. Some phlebotomists and nurses may be unaware (or forgot) that a minimum volume of blood is needed, despite the labeling on the bottle. Another factor is a lack of continuing education in the collection methods for blood culture bottles. Finally, it can be very difficult to get adequate draws in severally dehydrated, ill, septic, geriatric, or pediatric patients. Many laboratories have monitored fill volumes by visual examination or by weighing bottles with manual recording. However, this process is labor intensive and not sustainable in a high-volume clinical microbiology laboratory.
The Penn State Health Milton S. Hershey Medical Center admits approximately 28,500 patients per year with 420 and 128 licensed adult and pediatric beds, respectively, with 82 beds dedicated to intensive care. Education of the staff caring for the patients in these high-acuity units may have varying degrees of success. [6] [7] [8] [9] [10] [11] Education often has a positive effect initially but, without sustained continuous education, may be followed by a period of lesser positive effect over time. [12] [13] [14] We chose to focus our study on the high-acuity ICUs because of the specific and discrete group of dedicated staff caring for patients in the ICU, allowing for effective dissemination of fill volume data and educational seminars to the clinical staff that are collecting the blood cultures.
In response to the CAP initiative, we developed a program to monitor blood culture fill volumes and established a collaborative relationship with multiple health care professionals caring for high-acuity patients in our medical center. Recent studies suggest that increased laboratory staff communication with health care providers improves patient outcomes, as demonstrated by implementation of antimicrobial stewardship programs. 15 It was our objective to create a similar collaboration program for blood cultures with a specific emphasis on fill volume. We describe the various steps we took to create this program, analyze the results achieved, measure successes and failures, and collate lessons learned.
Materials and Methods
This program was divided into three approaches: installation and validation of the BD Epicenter automated volume monitor (BD, Sparks, MD), collection and dissemination of fill volume data in the form of utilization report cards, and clinical staff education. Data reporting and staff education occurred in two phases. Phase 1 consisted of blood volume report cards and education for a single high-acuity hospital unit. In phase 2, additional high-acuity hospital units were provided data and education. At the same time, the phase 1 high-acuity unit continued to receive report cards.
At our institution, a set of blood cultures consists of one aerobic and one anaerobic bottle. The standard protocol is to obtain two sets (four bottles total), with the suggested volume of 8 to 10 mL of blood in each bottle, giving a total volume of 32 to 40 mL of blood per blood culture. This volume is in accordance with the recommendations from our blood culture collection and incubation system (BACTEC; BD), as well as supported by the literature. 4, 5 Our microbiology laboratory does not reject underfilled blood culture bottles.
All educational sessions were in the form of a PowerPoint presentation, which consisted of a general overview of basic concepts of blood cultures, including the purpose of the blood culture, aseptic technique for collection, proper collection sites, and appropriate fill volume, and each session was concluded with a discussion of difficulties faced by the nursing staff when collecting samples. Emphasis was placed on obtaining the target of 8 to 10 mL per bottle with discussion on the potential consequences of over-and underfilling.
Utilization report cards were delivered on a monthly basis and showed the hospital unit's average blood culture collection volume per aerobic bottle in the form of a box plot. In addition, line graphs containing a compilation of the unit's entire average fill volume history were reported with each report card, allowing the units to gauge where their current month's volume stood in comparison to prior months, enabling the units to assess performance in underfilling, overfilling, and appropriate filling, as well as increasing or decreasing trends.
Education and report card feedback was delivered only to the nursing staff of the hospital units in this study. We chose to exclude phlebotomy in this study since most of the blood cultures drawn on these units were collected by the nursing staff.
BD Software Validation
The BD Epicenter system software is a proprietary algorithm that monitors blood volume in aerobic bottles and reports volumes electronically by the clinical unit after at least 25 bottles from a specific demographic (unit) have been received and incubated, regardless of the presence of organisms that would result in a positive. Using a proprietary algorithm, the system reports the volume of blood in an aerobic bottle from an estimation of blood background signal data, based on the basal metabolic activity of RBCs. This is the first published study to our knowledge that shows validation of the software in monitoring blood culture fill volume. To validate the BD Epicenter software, 50 aerobic culture bottles were inoculated with 5, 7, and 10 mL of blood drawn from a single, healthy donor, who had normal CBC parameters. Bottles were labeled (using dummy accession numbers) and placed in the incubator. After 120 hours, we accessed the blood fill volume database and compared the BD BACTEC FX software-calculated volumes to the known manually measured volumes.
Educational Sessions and Partnerships

Phase 1
We set up a partnership with the surgical ICU (SICU), as we had a previous working relationship with this unit due to contingency planning for caring for patients with highly pathogenic microorganisms. The SICU is a 30-bed unit with approximately 75 full-time nurses, 18 nurses per shift, and a 7% turnover rate at the time of this study. The nurses on this unit perform 100% of the blood culture draws. While the laboratory has a phlebotomy staff for routine blood draws at our institution, in the ICU setting, a significant percentage of the blood culture draws is performed by the nursing staff. We sent monthly laboratory report cards (in the form of a boxplot) to the SICU nurse manager that included current fill volume data and historical trends in blood volume for comparison. We asked the nurse manager to use this information to report to the nursing staff on a regular basis. We also held two educational sessions, which occurred 6 months apart.
Phase 2
Additional partnerships were established with the nurse managers of the medical intermediate care unit (MIMCU), medical ICU (MICU), and hematology and oncology unit (HEME/ONC). Blood cultures on these units were also collected by the nursing staff with some variation, with phlebotomists dependent on the shift in which they were collected.
The MIMCU is a 20-bed unit staffed by 45 total fulltime nurses, nine nurses per shift, and a turnover rate of 15% at the time of this study. Nurses on the MIMCU collect approximately 75% of the blood cultures.
The MICU is a 16-bed unit, staffed by 60 total fulltime nurses, 10 nurses per shift, and a turnover rate of less than 10% during the time of this study. Nurses on the MICU perform approximately 99% of the blood culture draws. HEME/ONC unit is a 39-bed unit staffed by a total of 65 full-time nurses, with 13 nurses per shift, and a turnover rate of less than 10% during the time of this study. The nursing staff of this unit collects 100% of the blood cultures.
Average blood culture fill volumes were tracked each month, and the data were sent as report cards to the nurse managers, who disseminated that information to the rest of the nursing staff. We began sending reports to the MIMCU and MICU at the same time, while HEME/ONC started receiving reports 3 months after. Educational sessions identical to the session described in phase 1 were given to all three units: MIMCU (March 27, 2017, and November 27, 2017), MICU (March 17, 2017; April 6, 2017; and April 13, 2017), and HEME/ ONC (July 5, 2017), and reports cards were continuously delivered on a monthly basis. Also, during phase 2 (beginning October 6, 2016), the SICU continued to receive monthly report cards, but additional educational sessions were not given.
Statistical Analysis
Student t test was used to test for a significant difference in the average blood culture fill volumes between preand postintervention of each hospital unit in this study. Microsoft Excel (Microsoft, Redmond, Washington) was used for all analysis. Statistical significance was defined as a P value of less than .05.
Results
Validation of the BD Epicenter
Comparison in techniques between manually measured blood volumes and BD BACTEC FX software-calculated volumes, from the same 50 aerobic blood culture bottles, was performed. Volume measurement techniques between the two methods resulted in an overall volume difference of 0.3 mL, which is well within the standard deviation. With successful validation of the software, we were able to obtain blood culture fill volume data for our entire institution, on a month-by-month basis. ❚Figure 1❚ demonstrates that our hospital as a whole consistently fails to collect the appropriate volume of blood (8-10 mL) on average for blood cultures.
Phase 1
The trends in blood volume in the SICU, shown in ❚Figure 2❚, highlight the trends before and after the educational sessions and monitoring period. Prior to intervention, this unit had an average blood culture fill volume of 4.8 mL/bottle (January 2014 to April 2015). The initial discussions and partnership with the SICU began in early 2015. The educational sessions took place on April 8, 2015 , and October 15, 2015. Following educational intervention, the average blood culture fill volume increased to 7.1 mL/bottle (P < .001).
Phase 2
MICU and MIMCU
Prior to any type of intervention (January 2014 to January 2017), both of these units had an average blood culture fill volume of 5 mL/bottle. After 1 month of initiating our education process with a single report card, the MIMCU instantly showed a 2.6-mL increase in its average blood culture fill volume, from 5.3 mL to 7.9 mL. Over the next 13 months, following only a single education session, the MIMCU was able to maintain an average fill volume of 7.9 mL (P < .001). From trough to peak (4.5-13 mL), this unit showed a 225% increase in its average blood culture fill volume ❚Figure 3❚.
The MICU showed results similar to the MIMCU, although delayed. After 4 months of report cards and three educational sessions, the MICU steadily increased 3.1 mL in its average blood culture fill volumes from 5 mL to 8.1 mL over the following 11 months after its final education session (P < .001). From trough to peak (4-9 mL), this unit showed a 125% increase in average blood culture fill volume ❚Figure 4❚.
HEME/ONC
Before intervention, from January 2014 to April 2017, this unit had an average blood culture fill volume of 6.3 mL. One month after our intervention began, this unit's average blood culture fill volume increased by 1.7 mL, from 6.3 mL to 8 mL. Following two education sessions, this unit maintained an average volume of 8.2 mL over 5 months (P < .001). From trough to peak (5.3-9.6 mL), this unit showed a 96% increase in average blood culture fill volume ❚Figure 5❚.
SICU
After completion of educational sessions during phase 1, this unit maintained an average blood culture fill volume of 6.8 mL/bottle over the following 30 months. From trough to peak (4.2-9.1 mL), this unit showed a 116% increase in average blood culture fill volume (Figure 2 ).
Discussion
Our data suggest that the BD Epicenter blood culture volume software can be validated in the clinical microbiology laboratory and may be reliably used as an automated system for monitoring blood culture bottle fill volume. With this newly acquired software, we were able to objectively demonstrate the presence of unapparent challenges associated with obtaining appropriate volumes of blood for cultures within our institution. Furthermore, the software allowed us to analyze the blood culture volume status of individual hospital units, which let us target our efforts to those units that were in most need of improvement. In addition, our data suggest that setting up a partnership with a specific unit with the use of monthly "report cards" and educational sessions does have a direct positive correlation on increasing blood culture fill volumes, as highlighted in Figures 3 to 5 . Not only does this study demonstrate that blood culture fill volumes can be increased through these methods, but it also shows that an educational approach is an effective and, more important, sustainable method. The SICU was able to maintain an average blood culture fill volume of 6.7 mL without further educational sessions, while only receiving monthly reports, compared with the unit's average fill volume of 4.8 mL prior to intervention. Moving forward, we anticipate that the additional hospital units we worked with in phase 2 will be as successful as the SICU in maintaining increased blood culture bottle fill volumes.
An interesting observation is that our educational initiative resulted in different outcomes in terms of improvement in average blood volumes collected. For example, the MICU reached the volume goal after three education sessions, while the MIMCU achieved the volume goal immediately following partnership, before its single education session. Such variations in response could be due to a multitude of factors, including size of the nursing staff, effectiveness of dissemination of feedback, and overall individual motivation.
Through our collaboration, we found that the senior staff in the units were very committed to increasing average fill volume and were surprised to see the fill volumes so low. The educational sessions by the laboratory director provided the scientific basis for why volume matters, and it appeared to make a difference to the nursing staff. We are currently advocating for providing these educational sessions to all nursing staff either during new employee orientation and/or as an online CME resource for more senior nurses. Also, a structured educational initiative directed toward our phlebotomy staff has been scheduled, which may help improve and sustain appropriate fill volumes on a hospital-wide level. A limitation in our study is that it was validated using a healthy donor who had completely normal CBC parameters, and since the method involves analyzing oxygen metabolism, it may not work as well in patients with low hematocrits. This is especially concerning given the fact that pancytopenic patients are obviously at risk for developing sepsis and thus the need for blood cultures. However, the purpose of this instrument is not to provide an accurate blood measurement for each individual bottle but to provide an aggregate "snapshot" of blood volume trends within a particular unit in the hospital. Also, the instrument is not reporting a clinical value but is a quality monitor and the only system we are aware of that can quickly and efficiently monitor blood volumes. We believe the best use of this system is to monitor trends with a goal to increase blood fill volume and share the information with the phlebotomists and clinical staff.
Because other strategies to monitor fill volumes are nonautomated and time-consuming, the BD Epicenter blood culture fill volume software represents a more cost-effective method to meet the new CAP initiative and potentially increase the sensitivity of blood culture. Additional studies are planned to expand clinical partnerships outside high-acuity ICU settings. It would also be interesting to see how average volume reports would differ between nursing and phlebotomy staff. Our desire is that this project may serve as a model for other laboratories to use to monitor and increase blood culture fill volumes and provide a means of continuing education to the clinical staff. Given the clear established link between blood volume and bacterial detection, our data suggest that the implementation of this software system will have a positive impact on patient care.
Conclusions
Our data show that partnering with a specific unit and providing monthly report cards with periodic educational sessions does have a direct positive correlation on increasing blood culture fill volumes.
Increasing blood volumes to the labeled fill volume for blood culture bottles also has the potential to decrease false-negative blood cultures, decrease time to detection of positive blood cultures, decrease time to appropriate and specific antimicrobial therapy, and improve patient outcomes in these high-acuity patient care units. Developing an educational approach to blood culture fill volumes appears to be an effective and sustainable method for increasing blood culture fill volumes in these clinical environments.
